The global Aortic Stenosis Market Growth Accelerated by Rising Prevalence of Valvular Heart Disease


 Aortic Stenosis is a condition caused due to the narrowing of the aortic valve opening, blocking the blood flow from the heart to the rest of the body. Valve replacement procedures are commonly preferred to treat severe Aortic Stenosis. With rising prevalence of valvular heart diseases such as aortic stenosis, the demand for prosthetic heart valves has increased significantly.

The global Aortic Stenosis Market is estimated to be valued at US$ 8.33 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Key Trends:

The rising prevalence of valvular heart disease due to growing geriatric population across the globe has emerged as a key trend fueling the growth of the aortic stenosis market. As per the data by the American Heart Association 2020, over 5 million people in the United States suffer from valvular heart disease, of which 2.8% population aged 75 or older have aortic stenosis. Moreover, aging impacts the aortic valve over time making it stiffer and less flexible to open fully. This leads to a narrowing of the aortic valve and lack of blood flow through it. With rising life expectancy, the number of patients diagnosed with aortic stenosis is projected to increase considerably during the forecast period.

Segment Analysis

The global aortic stenosis market can be segmented by type, procedural approach, and end user. Based on type, the transcatheter aortic valve replacement (TAVR) segment dominated the market in 2022 owing to its minimally invasive procedure and faster recovery time. TAVR requires no chest incision and only small incisions in the groin, minimizing pain, blood loss, and risk of infection. It has thus gained popularity among geriatric patients.

Key Takeaways

The global aortic stenosis market is expected to witness high growth over the forecast period of 2023 to 2030. The global Aortic Stenosis Market is estimated to be valued at US$ 8.33 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030.

Regional analysis shows that North America currently accounts for the largest share of the market due to advanced healthcare infrastructure and greater accessibility. However, Asia Pacific is poised to grow at the highest CAGR during the forecast period owing to increasing healthcare expenditure and growing patient awareness in countries such as China and India.

Key players operating in the aortic stenosis market include Boston Scientific Corporation, Medtronic plc, Abbott, LivaNova PLC, and Edwards Lifesciences Corporation. Boston Scientific holds the leading market share with its extensive TAVR device portfolio. Medtronic follows with its CoreValve and Evolut families of devices. Edwards Lifesciences also has a strong global presence driven by the strong brand recognition of its SAPIEN TAVR platforms.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more